Doc2 alpha as modulator of Ca(2+)-dependent exocytosis.
Orita
S
S
Discovery Research Laboratories, Shionogi and Company, Limited, Osaka 565-0871, Japan.
Sasaki
T
T
Takai
Y
Y
D000818:Animals; D002118:Calcium / Q000494:pharmacology*; D002135:Calcium-Binding Proteins / Q000302:isolation & purification / Q000378:metabolism*; D002474:Cell-Free System; D004926:Escherichia coli; D005089:Exocytosis / Q000187:drug effects*; D013006:Growth Hormone / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000302:isolation & purification / Q000378:metabolism*; D016716:PC12 Cells; D011188:Potassium / Q000494:pharmacology; D011233:Precipitin Tests; D011485:Protein Binding; D017434:Protein Structure, Tertiary; D051381:Rats; D011993:Recombinant Fusion Proteins / Q000302:isolation & purification / Q000378:metabolism; D013755:Tetradecanoylphorbol Acetate / Q000494:pharmacology; D014162:Transfection
D002135:Calcium-Binding Proteins; C490419:Doc2a protein, rat; D009419:Nerve Tissue Proteins; D011993:Recombinant Fusion Proteins; C485548:UNC13B protein, human; C103912:Unc13a protein, rat; D013006:Growth Hormone; D013755:Tetradecanoylphorbol Acetate; D011188:Potassium; D002118:Calcium